Why CannTrust (TSX:TRST) Shares Could Be Headed Even Lower

Removal from the S&P/TSX Composite Index could result in another sell-off of CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST), and there still might be more bad news to come.

Financial technology concept.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) continues getting hammered as the share price has fallen more than $10 from where it was earlier in the year. The problem for CannTrust investors that may be hoping for some sort of a miracle is that things could be about to get even worse for the stock.

Recently, The Globe and Mail reported that due to the company’s significant sell-off, the valuation has dropped enough that it’s likely going to be removed from the S&P/TSX Composite Index as soon as this month.

Many index funds will thus sell shares of CannTrust as a result, which could mean up to 4.8 million shares flood the market, putting even more downward pressure on the share price.

It may be hard to believe that the stock could go any lower, but it’s a very real possibility at this point. The expectation that there will be more shares on the market could also lead to more selling, as investors that may want to get out before that happens.

Decision from Health Canada still to come

The largest blow that could be dealt to the stock likely won’t come from it being removed from index funds, but it could come from Health Canada.

With a decision on the company’s alleged illegal operations still outstanding, it’s only a matter of time before we find out what punishment CannTrust will face for its violations.

While there’s no indication of what might happen to the company given that it now looks like multiple sites have run into problems, it’s hard to imagine CannTrust coming away with a light punishment.

The company has made changes to its leadership, but that may not be enough to keep it from facing a possible suspension of its license. Such a punishment would be catastrophic and likely send the sell-off to a whole new level.

Is there any reason left to hold shares of CannTrust?

Investors still holding shares of the company are taking on some significant risk, and it’s not a scenario that’s likely to play out well. The danger with buying a stock that has fallen so much in value is in believing that it’s reached a bottom.

In reality, a new bottom can always be around the corner, especially for a stock like CannTrust whose entire operations may be in jeopardy.

Even if by some miracle Health Canada allows CannTrust to keep operating, it would be a very uphill battle to earn back the trust of consumers and investors. Competition in the industry is getting more intense, and with plenty of cannabis stocks to choose from, CannTrust would have a difficult time convincing investors that it’s a better buy given the challenges it would face.

However, this is not a scenario that appears probable at this point, so a safer option for investors could be to salvage what they have left of their investments and simply sell any remaining shares in CannTrust. Just because the stock has fallen as much as it has doesn’t mean that it’s likely to bounce back up.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »